Cargando…
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by remodeling of the pulmonary arteries, increased pulmonary infiltrates, loss of vascular cross-sectional area, and elevated pulmonary vascular resistance. Despite recent advances in the management of PAH, there is a press...
Autores principales: | Willis, Gareth R., Fernandez-Gonzalez, Angeles, Reis, Monica, Mitsialis, S. Alex, Kourembanas, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164282/ https://www.ncbi.nlm.nih.gov/pubmed/30150544 http://dx.doi.org/10.3390/ijms19092534 |
Ejemplares similares
-
Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Yeung, Vincent, et al.
Publicado: (2019) -
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency
por: Willis, Gareth R., et al.
Publicado: (2017) -
‘Good things come in small packages’: Application of exosome-based therapeutics in neonatal lung injury
por: Willis, Gareth R, et al.
Publicado: (2017) -
Therapeutic Effects of Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles in Oxygen-Induced Multi-Organ Disease: A Developmental Perspective
por: Fernandez-Gonzalez, Angeles, et al.
Publicado: (2021) -
Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension
por: Hansmann, Georg, et al.
Publicado: (2012)